Skip to main content
. 2019 Nov 29;3:20. doi: 10.1186/s41824-019-0066-2

Fig. 30.

Fig. 30

68Ga-PSMA, prostate cancer, biochemical recurrence (BCR): specificity. Clinical history: 68 y.o. man with prostate cancer, prostatectomy as primary treatment, Gleason score 4 + 5; pT3N0Mx + adjuvant radiotherapy. Three years later: PSA = 2.49 ng/ml, PSAdt 8 months. PET/CT findings: no evidence of recurrent disease, but urinary activity is evident in the prostatic fossa and the urethra. a MIP in a lateral view; b CT, PET, and fused images